Healthcare Dive1h
A new, non-opioid pain drug is here. Getting it to patients could be agony.
After decades of research, Vertex Pharmaceuticals now has an approved pain medication. Can one of the world’s most powerful ...
BioPharma Dive5h
Vertex COO Arbuckle to step down later this year
Stuart Arbuckle, who’s been with Vertex since 2012, plans to retire from his role in July. His departure comes as Vertex ...
Vertex stock price target lifted to $444 by Bernstein
Bernstein SocGen Group adjusted its price target for Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX), increasing it slightly from $441.00 to $444.00 while maintaining a Market Perform rating. With a ...
Top Vertex exec to retire after more than 12 years with company
Vertex Pharmaceuticals Inc. will soon lose a member of its leadership team that helped the company achieve major revenue ...
Vertex's Revenue Surges but EPS Slips
The cystic fibrosis treatment leader exceeded revenue expectations, but missed slightly on earnings per share.
New York Magazine1d
Will Scalp Oiling Make My Hair Grow?
Scalp oiling boosts hair growth by stimulating blood flow to the scalp. Bridgette Hill, a trichologist and scalp therapist, ...
emjreviews.com3d
Scalp Microbiome and Central Centrifugal Cicatricial Alopecia
Discover a recent study that has examined the scalp microbiome in Black women diagnosed with central centrifugal cicatricial ...
dermatologyadvisor3d
Injectable Botulinum Toxin May be a Promising Option for Androgenetic Alopecia
Injectable botulinum toxin was associated with significant efficacy and sufficient safety outcomes in treating patients with androgenetic alopecia.
BioSpace4d
FDA Approval of Vertex’s Non-Opioid Journavx Signals New Era in Pain Treatment
If the attention generated by BioSpace’s coverage of this landmark approval is any indication, Americans are hungry for ...
FDA approves new pain medicine as opioid alternative. What to know about Journavx
The FDA has approved Journavx, a pain medication, offering a safer alternative to opioids. Learn about its benefits and side effects.
Wall Street Journal11d
Vertex Pharmaceuticals Inc.
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...